RESPONSE OF CORTICAL BONE TO ANTIRESORPTIVE AGENTS AND PARATHYROID-HORMONE IN AGED OVARIECTOMIZED RATS

被引:84
作者
BAUMANN, BD [1 ]
WRONSKI, TJ [1 ]
机构
[1] UNIV FLORIDA,J HILLIS MILLER HLTH CTR,COLL VET MED,DEPT PHYSIOL SCI,GAINESVILLE,FL 32610
关键词
AGED RATS; OVARIECTOMY; BONE HISTOMORPHOMETRY; CORTICAL BONE; BONE FORMATION; PARATHYROID HORMONE;
D O I
10.1016/8756-3282(94)00036-Y
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The purpose of this study was to determine whether PTH has anabolic effects on cortical bone in aged ovariectomized (OVX) rats treated during the late stages of estrogen depletion. Groups of OVX rats were untreated for 1 year postovariectomy followed by treatment for 10 weeks with vehicle, estrogen, the bisphosphonate risedronate (NE-58095), calcitonin (CT), PTH, PTH + estrogen, PTH + NE-58095 or PTH + CT. A group of sham-operated central rats was treated with vehicle alone. Cross-sections of the tibial diaphysis immediately proximal to the tibiofibular junction were subjected to quantitative bone histomorphometry. In comparison to vehicle-treated control rats, the following structural changes were detected in cortical bone of vehicle-treated OVX rats: increased cortical bone tissue area, increased bone marrow area and a significant decrease in cortical width. Indices of endocortical bone formation were also significantly increased in vehicle-treated OVX rats relative to vehicle-treated control rats. Treatment with the antiresorptive agents estrogen, NE-58095 or CT prevented the decrease in cortical width in OVX rats, but failed to increase cortical bone area. In comparison to vehicle treatment of OVX rats, estrogen and CT decreased both periosteal and endocortical bone formation, whereas NE-58095 decreased endocortical, but not periosteal, bone formation. In contrast, treatment of OVX rats with PTH alone increased cortical bone area and width as well as decreased bone marrow area compared to vehicle treatment of OVX rats. The PTH-induced increase in cortical bone mass was associated with a marked increase in periosteal and endocortical bone formation. Concurrent treatment of OVX rats with PTH + estrogen, PTH + NE-58095 or PTH + CT did not have a greater anabolic effect on cortical bone than treatment with PTH alone. The results indicate that PTH, in contrast to estrogen, NE-58095 and CT, stimulates cortical bone formation and augments cortical bone mass in the tibial diaphysis of aged OVX rats. Therefore, cortical bone of aged OVX rats retains its ability to respond anabolically to PTH even during the late stages of estrogen depletion.
引用
收藏
页码:247 / 253
页数:7
相关论文
共 30 条
  • [1] PRIMARY HYPERPARATHYROIDISM - ILIAC CREST CORTICAL THICKNESS, STRUCTURE AND REMODELING EVALUATED BY HISTOMORPHOMETRIC METHODS
    CHRISTIANSEN, P
    STEINICHE, T
    BROCKSTEDT, H
    MOSEKILDE, L
    HESSOV, I
    MELSEN, F
    [J]. BONE, 1993, 14 (03) : 403 - 408
  • [2] BONE TURNOVER IN POSTMENOPAUSAL OSTEOPOROSIS - EFFECT OF CALCITONIN TREATMENT
    CIVITELLI, R
    GONNELLI, S
    ZACCHEI, F
    BIGAZZI, S
    VATTIMO, A
    AVIOLI, LV
    GENNARI, C
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1988, 82 (04) : 1268 - 1274
  • [3] Conover WJ, 1980, PRACTICAL NONPARAMET, P229
  • [4] ANABOLIC ACTIONS OF PARATHYROID-HORMONE ON BONE
    DEMPSTER, DW
    COSMAN, F
    PARISIEN, M
    SHEN, V
    LINDSAY, R
    [J]. ENDOCRINE REVIEWS, 1993, 14 (06) : 690 - 709
  • [5] GASSER JA, 1992, TRIANGLE, V31, P111
  • [6] AN EFFECTIVE REGIMEN OF INTRANASAL SALMON-CALCITONIN IN EARLY POSTMENOPAUSAL BONE LOSS
    GENNARI, C
    AGNUSDEI, D
    MONTAGNANI, M
    GONNELLI, S
    CIVITELLI, R
    [J]. CALCIFIED TISSUE INTERNATIONAL, 1992, 50 (04) : 381 - 383
  • [7] LONG-TERM CALCITONIN THERAPY IN POSTMENOPAUSAL OSTEOPOROSIS
    GRUBER, HE
    IVEY, JL
    BAYLINK, DJ
    MATTHEWS, M
    NELP, WB
    SISOM, K
    CHESNUT, CH
    [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 1984, 33 (04): : 295 - 303
  • [8] LOSS OF THE ANABOLIC EFFECT OF PARATHYROID-HORMONE ON BONE AFTER DISCONTINUATION OF HORMONE IN RATS
    GUNNESSHEY, M
    HOCK, JM
    [J]. BONE, 1989, 10 (06) : 447 - 452
  • [9] THE RELATIONSHIP BETWEEN CHANGES IN FEMORAL BONE-DENSITY AND CALCIUM BALANCE IN PATIENTS WITH INVOLUTIONAL OSTEOPOROSIS TREATED WITH HUMAN PARATHYROID-HORMONE FRAGMENT (HPTH-1-34)
    HESP, R
    HULME, P
    WILLIAMS, D
    REEVE, J
    [J]. METABOLIC BONE DISEASE & RELATED RESEARCH, 1981, 2 (05): : 331 - 334
  • [10] HUMAN PARATHYROID HORMONE-(1-34) INCREASES BONE MASS IN OVARIECTOMIZED AND ORCHIDECTOMIZED RATS
    HOCK, JM
    GERA, I
    FONSECA, J
    RAISZ, LG
    [J]. ENDOCRINOLOGY, 1988, 122 (06) : 2899 - 2904